过去一年中添加的文章,按日期排序

[HTML][HTML] Systemic Metabolic and Volumetric Assessment via Whole-Body [18F]FDG-PET/CT: Pancreas Size Predicts Cachexia in Head and Neck Squamous Cell …

J Yu, C Spielvogel, D Haberl, Z Jiang, Ö Özer, S Pusitz… - Cancers, 2024 - mdpi.com
4 天前 - … This study uses advanced machine learning techniques to improve the … management
strategies. Our findings suggest that specific imaging biomarkers, particularly pancreatic

Long-Term Outcomes after Stereotactic Body Radiotherapy for Locally Advanced Pancreatic Cancer

AA Vera, AH Zureikat, M Lotze, A Paniccia… - International Journal of …, 2024 - redjournal.org
7 天前 - Purpose/Objective(s) Multiple early-phase studies have evaluated stereotactic body
radiation (SBRT) for locally advanced pancreatic cancer (LAPC). However, long-term follow …

The Outcomes of Moderately-Hypofractionated Intensity Modulated Radiotherapy for Unresectable Locally Advanced Pancreatic Cancer

M Yoshimura, T Iwai, Y Ono, M Kanai… - International Journal of …, 2024 - redjournal.org
7 天前 - management represented the most dominant cohort (n = 8). Conclusion: Tumors
near liver-tissue interfaces, particularly when treated with PBT and without motion management

Single Institution Treatment Outcomes for Patients Treated with SBRT for Borderline Resectable Pancreatic Cancer

LI Banla, DD Shi, YH Chen, M Rosenthal… - International Journal of …, 2024 - redjournal.org
7 天前 - pancreatic cancer, but few patients have resectable disease at diagnosis. Most present
with borderline resectable pancreatic cancer (… approaches to the management of BRPC. …

DDB2 expression lights the way for precision radiotherapy response in PDAC cells, with or without olaparib

J Dardare, A Witz, M Betz, A François, L Lamy… - Cell Death …, 2024 - nature.com
7 天前 - … offers hope for improving cancer management. Previously, … as a radiosensitizer in
pancreatic cancer cells, both in … study of locally advanced pancreatic cancer with gemcitabine …

[HTML][HTML] Curative intent treatment for pancreatic duct adenocarcinoma invade superior mesenteric vein

HP Hoang, D Le Thanh, KP Huu, TP Quang… - Radiology Case …, 2024 - Elsevier
10 天前 - … , surgical removal is still considered the cornerstone management option in this
situation. … underwent radical resection for advanced pancreatic cancer with superior mesenteric …

Mesenchymal stem cell-delivered paclitaxel nanoparticles exhibit enhanced efficacy against a syngeneic orthotopic mouse model of pancreatic cancer

PM Giri, A Banerjee, A Ghosal, P Salu, K Reindl… - International Journal of …, 2024 - Elsevier
10 天前 - Pancreatic cancer is considered the deadliest among … in the management of advanced
pancreatic cancer is the … cytotoxic effects against pancreatic cancer without altering their …

[HTML][HTML] Diagnostic and therapeutic strategies in pancreatic adenosquamous carcinoma: Molecular and clinical insights in managing metastatic disease

N Grabill, M Louis, M Cawthon, C Gherasim… - Radiology Case …, 2024 - Elsevier
15 天前 - … its efficacy in treating advanced pancreatic cancers, was administered with necessary
dose adjustments to accommodate the patient's tolerance and manage side effects such …

Intraductal Papillary Mucinous Neoplasm as a Precursor to Pancreatic Cancer

S Velastegui-Zurita… - Journal of Current …, 2024 - currentsurgery.org
17 天前 - … approaches, including both surgical and non-surgical options, offer promising
strategies for managing IPMN and preventing its progression to invasive pancreatic cancer. …

Abstract A067: Identifying and targeting FOLFIRINOX resistance mechanisms to improve outcomes in pancreatic cancer

…, S Ritchie, AA Pancreatic Cancer Matrix Atlas… - Cancer …, 2024 - aacrjournals.org
19 天前 - … Australian Pancreatic Cancer Matrix Atlas (APMA) and I have exposed them to 11
- 15 rounds of FOLFIRINOX (or vehicle control) in vivo to reflect the clinical management of …